Kern Pharma launches Flebikern® 500 mg
Kern Pharma | January 17, 2017
Kern Pharma, a leading company in the development, manufacture and production of medicines, launches Flebikern® 500 mg. This drug is indicated for the short-term relief of edema and symptoms associated with chronic venous insufficiency in adults, increasing the tone of the veins and the resistance of the capillaries (small blood vessels).